| Global prevalence and genotype distrbution of hepatitis C virus infection in 2015:a modelling study HCV Polaris, observatory collaborators Lancet Gastroenterology & Hepatology 2 (3), 161-76, 2017 | 2082 | 2017 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030:a modelling study EUHCV Collaborators Lancet Gastroenterology & Hepatolology, 325-36, 2017 | 309* | 2017 |
| Genome-wide Association Study of Anthropometric traits in Korčula Island, Croatia O Polašek, A Marušić, K Rotim, C Hayward, V Vitart, J Huffman, at al. Croatial medical Journal 1 (50), 7-16, 2009 | 50 | 2009 |
| Historical epidemiology of hepatitis C virus in select countries—volume 4 A Maaroufi, A Vince, SM Himatt, R Mohamed, J Fung, O Opare‐Sem, ... Journal of viral hepatitis 24, 8-24, 2017 | 44 | 2017 |
| Strategies to manage hepatitis C virus infection disease burden—Volume 4 DS Chen, W Hamoudi, B Mustapha, J Layden, A Nersesov, T Reic, ... Journal of viral hepatitis 24, 44-63, 2017 | 35 | 2017 |
| The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 HLY Chan, CJ Chen, O Omede, J Al Qamish, K Al Naamani, A Bane, ... Journal of viral hepatitis 24, 25-43, 2017 | 35 | 2017 |
| Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023 E Kissling, M Maurel, HD Emborg, H Whitaker, J McMenamin, J Howard, ... Eurosurveillance 28 (21), 2300116, 2023 | 22 | 2023 |
| Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study E Kissling, F Pozo, I Martínez‐Baz, S Buda, AM Vilcu, L Domegan, ... Influenza and other respiratory viruses 17 (1), e13069, 2023 | 19 | 2023 |
| Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE … KE al. Euro Surveillance 27 (22), 7-19, 2022 | 17* | 2022 |
| Anisakis Sensitization in the Croatian fish processing workers: Behavioral instead of occupational risk factors? A Jerončić, D Nonković, A Vrbatović, J Hrabar, I Bušelić, ... PLoS neglected tropical diseases 14 (1), e0008038, 2020 | 15 | 2020 |
| Strategies to eliminate hepatitis C in Croatia, a modelling study A Vince, E Dugan, T Nemeth-Blažić, T Filipec, I Hrstic, B Lukšić, ... Liječnički vjesnik 142 (9-10), 285-295, 2020 | 7 | 2020 |
| Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022 AMC Rose, N Nicolay, VS Martín, C Mazagatos, G Petrović, J Baruch, ... Eurosurveillance 28 (47), 2300187, 2023 | 6 | 2023 |
| Djeca i mladi u pandemiji COVID-19. Ž Karin, D Nonković, M Gotovac Lijecnicki Vjesnik 144, 2022 | 5 | 2022 |
| Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024 M Maurel, J Howard, E Kissling, F Pozo, G Pérez-Gimeno, S Buda, ... Eurosurveillance 29 (8), 2400089, 2024 | 3 | 2024 |
| Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha-and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 AMC Rose, N Nicolay, VS Martín, C Mazagatos, G Petrović, FA Niessen, ... Eurosurveillance 28 (47), 2300186, 2023 | 3 | 2023 |
| The Role of Platelet Function Analyzer Testing in Cardiac Surgery Transfusion Management D Bogdanić, N Karanović, J Mratinović-Mikulandra, B Puković-Sekulić, ... Transfusion Medicine and Hemotherapy 2 (44), 106-113, 2017 | 3 | 2017 |
| Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS … L Antunes, C Mazagatos, I Martínez-Baz, V Gomez, ML Borg, G Petrović, ... Eurosurveillance 29 (3), 2300708, 2024 | 2 | 2024 |
| Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study M Maurel, F Pozo, G Pérez‐Gimeno, S Buda, N Sève, B Oroszi, ... Influenza and Other Respiratory Viruses 18 (1), e13243, 2024 | 2 | 2024 |
| A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019 A Nardone, L Nerlander, E Duffell, M Valenciano, M Buti, C Marcos-Fosch, ... Eurosurveillance 28 (6), 2200184, 2023 | 2 | 2023 |
| Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A (H1N1) pdm09, A (H3N2) and B circulation, Europe: VEBIS SARI … AMC Rose, F Pozo, I Martínez‐Baz, C Mazagatos, N Bossuyt, JP Cauchi, ... Influenza and other respiratory viruses 18 (2), e13255, 2024 | 1 | 2024 |
